Dr. Fooke-Achterrath Laboratorien GmbH

Dr. Fooke-Achterrath Laboratorien GmbH is a German diagnostics company based in Neuss that specialises in in-vitro diagnostics, with a focus on allergy diagnostics, autoimmune diagnostics and microbiology. The company describes itself as a medium-sized enterprise whose aim is to develop, produce and sell modern and innovative tests for in-vitro allergy and autoimmune diagnosis. Its work has grown into a comprehensive product range intended to offer almost every user a solution precisely tailored to their needs. The company's core activities are grouped around several diagnostic areas. In allergy diagnostics it offers in-vitro allergy testing, including molecular allergy diagnostics using recombinant or native allergens for type I allergy diagnosis, and it highlights the reliable measurement of specific IgE with clinical relevance. Its ALLERG-O-LIQ system is a reverse assay for the quantitative determination of specific IgE and total IgE, while the ALFA rapid test (Allergy Lateral Flow Assay) is a first-line screening test that determines specific IgE or total IgE within 15 to 20 minutes. In autoimmune diagnostics the company supplies autoimmune ELISA kits, and it also works in microbiology and in the testing of food, drinking water and cosmetics under accreditation according to DIN EN ISO/IEC 17025. As a medium-sized company, Dr. Fooke-Achterrath Laboratorien emphasises its ability to react quickly and flexibly and to respond individually to customers, working out new concepts and solutions together with them. Its team includes biologists, biotechnologists and medical device consultants who support the continuous development and optimisation of the product range. The company positions itself not merely as a supplier but as a partner to its customers, offering technical and theoretical support in allergy and autoimmune diagnostics. The company has been recognised for its innovation: according to its website it has been included among Germany's Top 100 most innovative companies for 2024, 2025 and 2026, described as the third consecutive time it has received this honour. The company is headquartered in Neuss, Germany, and operates in the in-vitro diagnostics market.

Dr. Fooke-Achterrath Laboratorien GmbH is a German in-vitro diagnostics company located in Neuss. According to its own account, it has pursued for decades the aim of developing, producing and selling modern and innovative tests for in-vitro allergy and autoimmune diagnosis. The company states that it has more than 35 years of experience in in-vitro diagnostics, and its 'About Us' page describes a 30-year effort to build highly developed in-vitro allergy and autoimmune test systems that have grown into a comprehensive product range. Over that period the company built a portfolio spanning allergy diagnostics, autoimmune diagnostics and microbiology. In allergy diagnostics it developed the ALLERG-O-LIQ system, a reverse assay for the quantitative determination of allergen-specific IgE and total IgE with high sensitivity, and the ALFA rapid test (Allergy Lateral Flow Assay), a first-line screening test that determines specific IgE or total IgE within 15 to 20 minutes. It also moved into molecular allergy diagnostics, using recombinant or native allergens in type I allergy diagnosis to identify sensitisation patterns and risk markers. In autoimmune diagnostics it offers autoimmune ELISA kits, and it carries out accredited testing of food, drinking water and cosmetics under DIN EN ISO/IEC 17025. As a medium-sized company, Dr. Fooke-Achterrath Laboratorien has emphasised flexibility and close customer relationships, with a team of biologists, biotechnologists and medical device consultants supporting continuous development and optimisation of its products. The company has also been recognised for innovation, stating that it has been included among Germany's Top 100 most innovative companies for 2024, 2025 and 2026, which it describes as the third consecutive time it has received this honour. The company remains active in the in-vitro diagnostics market from its base in Neuss, Germany.

• Company states more than 35 years of experience in in-vitro diagnostics

• Included among Germany's Top 100 most innovative companies for 2024

• Included among Germany's Top 100 most innovative companies for 2025

• Included among Germany's Top 100 most innovative companies for 2026, described as the third consecutive time

Medium-sized, flexible in-vitro diagnostics specialist offering tailored allergy and autoimmune testing solutions and acting as a partner rather than a mere supplier.

• ALLERG-O-LIQ system

  Reverse assay for the quantitative determination of allergen-specific IgE and total IgE with high sensitivity.

• ALFA (Allergy Lateral Flow Assay)

  Rapid first-line screening test that determines specific IgE or total IgE within 15-20 minutes.

• Autoimmune ELISA kits

  Kits for autoimmune diagnostics.

• Molecular allergy diagnostics

  Use of recombinant or native allergens in type I allergy diagnosis to identify sensitisation patterns and risk markers.

1. 1Allergie | Diagnostik | Dr. Fooke-Achterrath Laboratorien GmbH | Neussfooke-labs.de
2. 2ÜBER UNS | Dr. Fooke GmbHfooke-labs.de
3. 3Dr. Fooke-Achterrath Laboratorien GmbH (Germany) - Wikidatawikidata.org